Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Companies 0/25
Result 21,068 decisions over 12 months
Reset filters
Minimum amount ? Share of their own holding ?
What the chief executive holds ?
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
21 Oct 2025
Executive Chairman indirect
Bought 2×
10,991
$783.71K
0.2%
21 Oct 2025
Director indirect
Sold at will
25,027
$703.51K
1.8%
21 Oct 2025
10% owner
Sold at will
189,300
$668.36K
5.3%
21 Oct 2025
10% owner indirect
Sold at will
189,300
$668.36K
5.3%
21 Oct 2025
Co-Chief Executive Officer indirect
Bought
26,680
$499.98K
53.4%
21 Oct 2025
Co-Chief Executive Officer indirect
Bought
26,680
$499.98K
53.4%
21 Oct 2025
Director
Sold at will
6,704
$331.89K
100%
21 Oct 2025
10% owner
Sold at will
92,352
$277.52K
24.9%
21 Oct 2025
Chief Human Resources Officer
Sold at will 6×
1,762
$272.32K
11.6%
21 Oct 2025
SVP/Co-Head of Global Business
Sold at will
1,511
$227.06K
91.2%
21 Oct 2025
10% owner
Sold at will
284,394
$119.56K
0.9%
21 Oct 2025
SVP, Chief Legal Officer
Bought
10,000
$118.10K
12.0%
20 Oct 2025
Senior Managing Director
Sold at will 9×
12,000
$13.98M
62.5%
20 Oct 2025
Director
Sold at will
140,445
$6.51M
9.4%
20 Oct 2025
10% owner indirect
Sold at will 25×
44,181
$6.04M
12.3%
20 Oct 2025
10% owner indirect
Sold at will
36,762
$5.18M
1.3%
20 Oct 2025
10% owner indirect
Sold at will
1,923,000
$4.64M
23.2%
20 Oct 2025
10% owner
Bought 2×
225,000
$4.03M
7.1%
20 Oct 2025
Director indirect
Sold at will 4×
92,023
$2.73M
100%
20 Oct 2025
President & CEO
Bought
55,000
$2.03M
×17
20 Oct 2025
Director
Sold at will
6,493
$1.91M
39.6%
20 Oct 2025
CVP, Chief Accounting Officer
Sold at will
8,800
$1.85M
17.9%
20 Oct 2025
Senior EVP and General Counsel
Sold at will
26,909
$1.26M
10.6%
20 Oct 2025
SVP - CLO & Corp Secy
Sold at will
24,249
$891.39K
32.0%
20 Oct 2025
Executive Chairman indirect
Bought 4×
12,279
$853.39K
0.2%
20 Oct 2025
10% owner
Sold at will
201,000
$719.26K
5.3%
20 Oct 2025
10% owner indirect
Sold at will
201,000
$719.26K
5.3%
20 Oct 2025
10% owner
Sold at will
37,500
$614.63K
1.6%
20 Oct 2025
10% owner indirect
Bought
11,566
$579.46K
0.2%
20 Oct 2025
10% owner
Sold at will
11,616
$349.10K
1.0%
20 Oct 2025
10% owner
Sold at will
108,107
$333.83K
22.5%
20 Oct 2025
President & CEO indirect
Bought
20,000
$272.79K
4.5%
20 Oct 2025
VP, Ag ODC; President, Amlan
Sold at will
4,025
$238.20K
13.9%
20 Oct 2025
Director
Sold at will
50,000
$233.25K
5.2%
20 Oct 2025
10% owner indirect
Sold at will
8,258
$191.34K
0.2%
20 Oct 2025
10% owner
Sold at will
75,000
$186.16K
13.2%
20 Oct 2025
Chief Executive Officer
Bought
12,000
$184.32K
20.5%
20 Oct 2025
Director
Bought 2×
3,000
$123.65K
3.7%
20 Oct 2025
CHIEF EXECUTIVE OFFICER indirect
Sold at will
7,500
$116.00K
17.6%
20 Oct 2025
10% owner
Bought
7,000
$104.73K
0.2%
20 Oct 2025
PRESIDENT AND CEO indirect
Bought
7,000
$104.73K
0.2%
20 Oct 2025
SENIOR VICE PRESIDENT indirect
Bought
7,000
$104.73K
0.2%
20 Oct 2025
Director indirect
Bought 2×
1,722
$100.04K
34.4%
17 Oct 2025
10% owner
Bought
643,850
$258.83B
opened
17 Oct 2025
10% owner indirect
Sold at will 36×
262,574
$35.87M
45.5%
17 Oct 2025
President & CEO
Sold at will 10×
2,533
$10.18M
97.9%
17 Oct 2025
Executive Chairman
Sold at will 4×
40,000
$8.31M
3.1%
17 Oct 2025
Director indirect
Sold at will 6×
260,859
$7.67M
94.5%
17 Oct 2025
Director indirect
Sold at will 14×
70,000
$6.22M
15.4%
17 Oct 2025
EVP, Innovative Medicine, R&D
Sold at will
21,721
$4.19M
67.1%
Showing 20,651–20,700 of 21,068. ← Newer Page 414 of 422 Older →